In April 2024, Entera announced that the Journal of Bone and Mineral Research (JBMR) published EB613 placebo controlled Phase ...
BMS-986458 features three stereocenters, one of which epimerizes easily, Mortensen said. The drug candidate, which would be ...
As per the scheme's terms, the merger will take effect from the first business day of the month following the fulfilment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback